AGC Biologics Honored for Innovations in Cell Line Development
13 oct. 2022 08h37 HE
|
AGC Biologics
Seattle, Oct. 13, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has been named a 2022...
AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
07 sept. 2022 17h00 HE
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
20 août 2021 13h39 HE
|
AGC Biologics
COPENHAGEN, Aug. 20, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new...
AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site
09 août 2021 13h00 HE
|
AGC Biologics
LONGMONT, Aug. 09, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new leadership appointment...
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
05 août 2021 12h00 HE
|
AGC Biologics
Seattle, Aug. 05, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of...
AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
02 août 2021 14h00 HE
|
AGC Biologics
Seattle, Aug. 02, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee...
AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
01 juil. 2021 12h00 HE
|
AGC Biologics
Seattle, July 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement...
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
23 juin 2021 08h30 HE
|
AGC Biologics
TEL AVIV, Israel and SEATTLE, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd. (NASDAQ: CMMB), a clinical-stage biotech company focused on the discovery and development of...
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
07 juin 2021 10h06 HE
|
AGC Biologics
Seattle, June 07, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech...
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
19 mai 2021 13h10 HE
|
AGC Biologics
Seattle, May 19, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced their win of the M&A Award for...